Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Entheogens of Amanita Muscaria Mushroom
SSP Modern Pharmacy and Medicine – July 18, 2023
Source: OpenAlex
Summary
The use of *Amanita* mushrooms for their hallucinogenic effects in smoking mixtures is deemed irrational. A multidisciplinary evaluation, involving seven distinct types of Medical and Pharmaceutic Studies, analyzed the risks. This comprehensive assessment, crucial for Psychedelics and Drug Studies, examined *Amanita muscaria* as a source of psilocybin. It highlighted dangers of mushroom poisoning, informing on pharmaceutical safety and toxicology. While some traditional medicine uses exist, this research on medicinal plant effects and applications emphasizes the need for regulatory initiatives concerning these potent fungi, warning against their misuse as medicine.
Abstract
A multidisciplinary pharmacognostic, forensic and pharmaceutical, organizational and legal, clinical and pharmacological, forensic and medical, toxicological, chemical evaluation of the irrational use of spices in smoking mixtures from the group of entheogens was carried out. An expert assessment of spices – plants and mushrooms containing psychoactive substances with hallucinogenic effects. Forensic and pharmaceutical practice was analyzed. A conclusion was made about the irrational use of smoking mixtures from the group of entheogens of the amanita muscaria mushroom, which contain psychoactive substances – psilocybin or psilocin. A forensic medical and toxicological study of amanita poisoning was conducted. Informed about pharmaceutical safety measures in case of amanita poisoning. A pharmacognostic study of "Amanita muscaria" – a fly agaric mushroom was conducted. According to the results of the normative study of the features of the circulation of fly agaric entheogens, normative initiatives are proposed.